Tradename | Company | Number | Date | Products |
---|---|---|---|---|
LIORESAL | Amneal Pharmaceuticals | N-020075 RX | 1992-06-17 | 3 products, RLD, RS |
LYVISPAH | Amneal Pharmaceuticals | N-215422 RX | 2021-11-22 | 3 products, RLD, RS |
FLEQSUVY | Azurity | N-215602 RX | 2022-02-04 | 1 products, RLD, RS |
OZOBAX DS | Metacel Pharmaceuticals | N-208193 RX | 2023-10-12 | 1 products, RLD, RS |
GABLOFEN | Piramal Critical Care | N-022462 RX | 2010-11-19 | 4 products, RLD, RS |
Brand Name | Status | Last Update |
---|---|---|
baclofen | ANDA | 2024-02-08 |
baclofen (intrathecal) | ANDA | 2023-11-08 |
fleqsuvy | New Drug Application | 2023-02-27 |
gablofen | New Drug Application | 2022-12-24 |
kemstro | 2006-01-04 | |
lioresal | New Drug Application | 2016-10-07 |
lioresal (baclofen) | New Drug Application | 2022-12-14 |
lyvispah | New Drug Application | 2023-04-20 |
ozobax | New Drug Application | 2023-10-17 |
Patent | Expires | Flag | FDA Information |
---|---|---|---|
Baclofen, Lyvispah, Amneal | |||
11491125 | 2041-09-29 | DP | U-3488, U-3489 |
11850225 | 2041-09-29 | DP | U-3488, U-3489 |
10792262 | 2039-07-29 | DP | U-3263 |
11654124 | 2039-07-29 | DP | |
Baclofen, Ozobax, Metacel Pharms Llc | |||
10610502 | 2039-08-30 | U-2779 | |
Baclofen, Fleqsuvy, Azurity | |||
11324696 | 2037-09-29 | DP | |
11446246 | 2037-09-08 | U-3433 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Alcoholism | D000437 | EFO_0003829 | F10.1 | 2 | 8 | 6 | 4 | 3 | 20 |
Cerebral palsy | D002547 | — | G80 | 1 | 2 | 1 | 3 | 4 | 10 |
Gastroesophageal reflux | D005764 | EFO_0003948 | K21 | 1 | 3 | 1 | 1 | 3 | 9 |
Muscle spasticity | D009128 | HP_0001257 | — | — | 2 | 1 | 2 | 1 | 6 |
Pain | D010146 | EFO_0003843 | R52 | — | — | 2 | 2 | — | 4 |
Alcohol withdrawal delirium | D000430 | EFO_1000800 | — | — | 1 | — | 1 | 2 | 4 |
Stroke | D020521 | EFO_0000712 | I63.9 | — | — | — | 1 | 1 | 2 |
Hemiplegia | D006429 | HP_0011099 | G81.0 | — | — | — | 1 | — | 1 |
Overactive urinary bladder | D053201 | EFO_1000781 | N32.81 | — | — | — | 1 | — | 1 |
Lower urinary tract symptoms | D059411 | EFO_0008008 | — | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Multiple sclerosis | D009103 | EFO_0003885 | G35 | — | 1 | 5 | — | 3 | 9 |
Fragile x syndrome | D005600 | — | Q99.2 | 1 | 2 | 1 | — | — | 4 |
Charcot-marie-tooth disease | D002607 | EFO_0004148 | G60.0 | — | — | 2 | — | — | 2 |
Analgesia | D000698 | — | — | — | 1 | 1 | — | — | 1 |
Acute pain | D059787 | — | R52 | — | 1 | 1 | — | — | 1 |
Knee osteoarthritis | D020370 | EFO_0004616 | M17 | — | 1 | 1 | — | — | 1 |
Female genital diseases | D005831 | EFO_0009549 | N85 | — | 1 | 1 | — | — | 1 |
Leukemia | D007938 | — | C95 | — | — | 1 | — | — | 1 |
Myelodysplastic syndromes | D009190 | — | D46 | — | — | 1 | — | — | 1 |
Neoplasms | D009369 | — | C80 | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Spinal cord injuries | D013119 | EFO_1001919 | — | 1 | 1 | — | — | 3 | 5 |
Autism spectrum disorder | D000067877 | HP_0000729 | F84.0 | — | 3 | — | — | 2 | 5 |
Cocaine-related disorders | D019970 | — | F14 | — | 4 | — | — | — | 4 |
Liver cirrhosis | D008103 | EFO_0001422 | K74.0 | — | 1 | — | — | 3 | 4 |
Tobacco use disorder | D014029 | — | F17 | — | 3 | — | — | — | 3 |
Traumatic brain injuries | D000070642 | — | S06 | — | 1 | — | — | 2 | 3 |
Alcohol drinking | D000428 | EFO_0004329 | — | — | 1 | — | — | 1 | 2 |
Alzheimer disease | D000544 | EFO_0000249 | F03 | — | 2 | — | — | — | 2 |
Muscle cramp | D009120 | HP_0003394 | — | — | 1 | — | — | 1 | 2 |
Marijuana abuse | D002189 | EFO_0007191 | F12 | — | 2 | — | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 5 | — | — | — | 1 | 6 |
Osteoarthritis | D010003 | EFO_0002506 | M15-M19 | 1 | — | — | — | — | 1 |
Substance-related disorders | D019966 | EFO_0003890 | F13 | 1 | — | — | — | — | 1 |
Neonatal abstinence syndrome | D009357 | EFO_0005799 | P96.1 | 1 | — | — | — | — | 1 |
Autistic disorder | D001321 | HP_0000717 | F84.0 | 1 | — | — | — | — | 1 |
Cheyne-stokes respiration | D002639 | — | R06.3 | 1 | — | — | — | — | 1 |
Ataxia telangiectasia | D001260 | Orphanet_100 | G11.3 | 1 | — | — | — | — | 1 |
Pharmacokinetics | D010599 | — | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Migraine disorders | D008881 | EFO_0003821 | G43 | — | — | — | — | 1 | 1 |
Headache | D006261 | HP_0002315 | R51 | — | — | — | — | 1 | 1 |
Arthritis | D001168 | HP_0001369 | M05-M14 | — | — | — | — | 1 | 1 |
Tendinopathy | D052256 | EFO_1001434 | M77.9 | — | — | — | — | 1 | 1 |
Synovitis | D013585 | EFO_0008997 | M67.5 | — | — | — | — | 1 | 1 |
Spasm | D013035 | — | M62.83 | — | — | — | — | 1 | 1 |
Radiculopathy | D011843 | — | M54.1 | — | — | — | — | 1 | 1 |
Gout | D006073 | EFO_0004274 | M10 | — | — | — | — | 1 | 1 |
Feeding and eating disorders | D001068 | — | F50 | — | — | — | — | 1 | 1 |
Bulimia nervosa | D052018 | EFO_0005204 | F50.2 | — | — | — | — | 1 | 1 |
Drug common name | Baclofen |
INN | baclofen |
Description | Baclofen is a monocarboxylic acid that is butanoic acid substituted by an amino group at position 4 and a 4-chlorophenyl group at position 3. It acts as a central nervous system depressant, GABA agonist and muscle relaxant. It has a role as a muscle relaxant, a central nervous system depressant and a GABA agonist. It is a monocarboxylic acid, a primary amino compound, a member of monochlorobenzenes and a gamma-amino acid. It is a tautomer of a baclofen zwitterion. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | NCC(CC(=O)O)c1ccc(Cl)cc1 |
PDB | — |
CAS-ID | 1134-47-0 |
RxCUI | — |
ChEMBL ID | CHEMBL701 |
ChEBI ID | 2972 |
PubChem CID | 2284 |
DrugBank | DB00181 |
UNII ID | H789N3FKE8 (ChemIDplus, GSRS) |